Biological therapy and the immune system in patients with chronic myeloid leukemia.
about
New insights into antigen specific immunotherapy for chronic myeloid leukemiaAdoptive T-cell therapy for hematological malignancies using T cells gene-modified to express tumor antigen-specific receptors.Interferon-alpha for the therapy of myeloproliferative neoplasms: targeting the malignant clone.L-amino acid oxidase isolated from Bothrops pirajai induces apoptosis in BCR-ABL-positive cells and potentiates imatinib mesylate effect.Chronic exposure to IFNα drives medullar lymphopoiesis towards T-cell differentiation in mice.Assessment of bone marrow lymphocytic status during tyrosine kinase inhibitor therapy and its relation to therapy response in chronic myeloid leukaemia.
P2860
Biological therapy and the immune system in patients with chronic myeloid leukemia.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Biological therapy and the immune system in patients with chronic myeloid leukemia.
@en
type
label
Biological therapy and the immune system in patients with chronic myeloid leukemia.
@en
prefLabel
Biological therapy and the immune system in patients with chronic myeloid leukemia.
@en
P2860
P1476
Biological therapy and the immune system in patients with chronic myeloid leukemia.
@en
P2093
Peter Rohon
P2860
P2888
P356
10.1007/S12185-012-1116-8
P577
2012-06-04T00:00:00Z
P6179
1012584986